Literature DB >> 9148091

Maximal exercise hemodynamics and risk of mortality in apparently healthy men and women.

H W Kohl1, M Z Nichaman, R F Frankowski, S N Blair.   

Abstract

The purpose of this investigation was to determine the association of maximal exercise hemodynamic responses with risk of mortality due to all-causes, cardiovascular disease (CVD), and coronary heart disease (CHD) in a population of apparently healthy individuals. Study participants were 20,387 men (mean age = 42.2 yr) and 6,234 women (mean age = 41.9 yr), patients of a preventive medicine center in Dallas, TX, examined between 1971 and 1989. Maximal heart rate and maximal systolic blood pressure (SBP) measured during the maximal exercise test were related to risk of all-cause, CVD, and CHD mortality. During an average of 8.1 yr of follow-up, there were 348 deaths in men and 66 deaths in women. Among men, after adjustment for confounding variables, risks (and 95 percent confidence interval (CI)) of all-cause mortality for quartiles of maximal SBP, relative to the lowest quartile, were: 0.96 (0.70-1.33), 1.36 (1.01-1.85), and 1.37 (0.98-1.92) for quartiles 2-4, respectively. Similarly adjusted risks for maximal heart rate were: 0.61(0.44-0.85), 0.69 (0.51-0.93), and 0.60 (0.41-0.87). Similar results were seen for risk of CVD and CHD death. In women, similar trends in adjusted risks of all-cause and CVD mortality across maximal SBP and heart rate categories were observed. For maximal heart rate, a 35 bpm higher value was associated with a 36 percent decreased risk of CVD mortality in men (RR = 0.63,95 percent CI = 0.34-0.71) and an 8 percent lower risk in women (RR = 0.92,95 percent CI = 0.18-4.63). These results suggest that an exaggerated SBP or an attenuated heart rate response to maximal exercise may indicate an elevated risk for mortality in this apparently healthy population.

Entities:  

Mesh:

Year:  1996        PMID: 9148091     DOI: 10.1097/00005768-199605000-00011

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  7 in total

1.  A systematic review of the evidence for Canada's Physical Activity Guidelines for Adults.

Authors:  Darren Er Warburton; Sarah Charlesworth; Adam Ivey; Lindsay Nettlefold; Shannon Sd Bredin
Journal:  Int J Behav Nutr Phys Act       Date:  2010-05-11       Impact factor: 6.457

2.  The influence of the carotid baroreflex on dynamic regulation of cerebral blood flow and cerebral tissue oxygenation in humans at rest and during exercise.

Authors:  Sushmita Purkayastha; Kaitlyn Maffuid; Xiaojie Zhu; Rong Zhang; Peter B Raven
Journal:  Eur J Appl Physiol       Date:  2018-03-01       Impact factor: 3.078

Review 3.  Blood Pressure Response to Exercise and Cardiovascular Disease.

Authors:  Martin G Schultz; Andre La Gerche; James E Sharman
Journal:  Curr Hypertens Rep       Date:  2017-10-18       Impact factor: 5.369

4.  Association of exercise heart rate response and incidence of hypertension in men.

Authors:  Vivek K Prasad; Gregory A Hand; Xuemei Sui; Deepika Shrestha; Duck-Chul Lee; Carl J Lavie; Jason R Jaggers; Steven N Blair
Journal:  Mayo Clin Proc       Date:  2014-06-25       Impact factor: 7.616

5.  Impaired glucose metabolism and the exaggerated blood pressure response to exercise treadmill testing in normotensive patients.

Authors:  Maria V Papavasileiou; Costas Thomopoulos; Ilias Antoniou; Georgios Papadimitriou; Maria Seferou; Thomas K Makris
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-11       Impact factor: 3.738

Review 6.  Exercise Hypertension.

Authors:  Martin G Schultz; James E Sharman
Journal:  Pulse (Basel)       Date:  2014-04-11

7.  Immediate post-exercise blood pressure and arterial compliance in middle-aged and older normotensive females: A cross-sectional study.

Authors:  Eduardo C Costa; Kevin F Boreskie; D Scott Kehler; David E Kent; Jacqueline L Hay; Rakesh C Arora; Rodrigo A V Browne; Todd A Duhamel
Journal:  Sci Rep       Date:  2020-06-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.